The use of everolimus to reverse tamoxifen resistance in men with metastatic breast cancer: a case report

被引：7
|
作者：
Kattan, Joseph [1 ]
Kourie, Hampig Raphael [1 ]
机构：
[1] St Joseph Univ, Dept Hematol Oncol, Fac Med, Beirut, Lebanon
来源：
INVESTIGATIONAL NEW DRUGS | 2014年 / 32卷 / 05期
关键词：
Tamoxifen; Everolimus; Exemestane; Hormone Resistance; Tamoxifen Resistance;
D O I：
10.1007/s10637-014-0133-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1046 / 1047
页数：2
相关论文
共 50 条
  • [41] Association of tamoxifen resistance and lipid reprogramming in breast cancer
    Hultsch, Susanne
    Kankainen, Matti
    Paavolainen, Lassi
    Kovanen, Ruusu-Maaria
    Ikonen, Elina
    Kangaspeska, Sara
    Pietiainen, Vilja
    Kallioniemi, Olli
    BMC CANCER, 2018, 18
  • [42] Association of tamoxifen resistance and lipid reprogramming in breast cancer
    Susanne Hultsch
    Matti Kankainen
    Lassi Paavolainen
    Ruusu-Maaria Kovanen
    Elina Ikonen
    Sara Kangaspeska
    Vilja Pietiäinen
    Olli Kallioniemi
    BMC Cancer, 18
  • [43] The correlation between autophagy and tamoxifen resistance in breast cancer
    Liu, Junxia
    Yue, Wei
    Chen, Haiyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (06): : 2066 - 2074
  • [44] miRNAs as emerging predictors of tamoxifen resistance in breast cancer
    Beilankouhi, Elmira Aboutalebi Vand
    Safaralizadeh, Reza
    Nejati, Babak
    Sanaat, Zohreh
    Gharamaleki, Jalil Vaez
    Esfahani, Ali
    Gholami, Nasrin
    Sarbakhsh, Parvin
    Mohammadian, Jamal
    Mehdizadeh, Amir
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [45] Everolimus-associated cytomegalovirus colitis in a patient with metastasized breast cancer: a case report
    Jie-Ru Yang
    Yen-Chen Shao
    Breast Cancer, 2020, 27 : 776 - 779
  • [46] Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report
    Shen, Ling
    Hong, Liangli
    Zhang, Guohong
    Mai, Ruiqin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (08): : 5295 - 5301
  • [47] Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
    Yao, Jingwei
    Deng, Kun
    Huang, Jialu
    Zeng, Ruimin
    Zuo, Jianhong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [48] Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer
    Kuik, Kelvin Teck-Hong
    Trubiano, Jason
    Worth, Leon J.
    Harun, Nur-shirin
    Steinfort, Daniel
    Johnson, Douglas
    MEDICAL MYCOLOGY CASE REPORTS, 2014, 6 : 34 - 36
  • [49] Malignant mixed mullerian tumor of the uterus following tamoxifen for breast cancer: Case report
    Saim, M.
    Cote, J. -F.
    More, O.
    Malartic, C.
    Akerman, G.
    Gray, F.
    Barranger, E.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2008, 36 (02): : 166 - 168
  • [50] Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer
    Masahide Fukudo
    Kei Ishibashi
    Masahiro Kitada
    Investigational New Drugs, 2021, 39 : 1707 - 1715
12345